Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

A Challenging Case of Advanced Cardiac Sarcoidosis Refractory to Infliximab Therapy.

Created on 04 Aug 2026

Authors

Manal Ibrahim, Mansimran Singh Dulay, Kshama Wechalekar, Vasileios Kouranos, Rakesh Sharma

Published in

Clinical case reports. Volume 14. Issue 8. Pages e73227. Epub Aug 02, 2026.

Abstract

Cardiac sarcoidosis can be life-threatening, and lack of response to immunosuppressive therapy remains a significant challenge in active disease. We present a case of refractory cardiac sarcoidosis despite third-line immunosuppression (infliximab). Ongoing multimodality assessment is essential for managing refractory cardiac sarcoidosis.

PMID:
42548916
Bibliographic data and abstract were imported from PubMed on 04 Aug 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 4
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement